A detailed history of ETF Managers Group, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, ETF Managers Group, LLC holds 8,410 shares of MRNA stock, worth $998,687. This represents 0.05% of its overall portfolio holdings.

Number of Shares
8,410
Previous 5,478 53.52%
Holding current value
$998,687
Previous $983,000 31.33%
% of portfolio
0.05%
Previous 0.05%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 17, 2023

BUY
$135.66 - $197.02 $397,755 - $577,662
2,932 Added 53.52%
8,410 $1.29 Million
Q4 2022

Mar 23, 2023

SELL
$118.38 - $210.04 $4.36 Million - $7.73 Million
-36,789 Reduced 87.04%
5,478 $983,000
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $3.71 Million - $6.1 Million
31,429 Added 289.99%
42,267 $5 Million
Q2 2022

Aug 15, 2022

SELL
$117.13 - $176.59 $366,968 - $553,256
-3,133 Reduced 22.43%
10,838 $1.55 Million
Q1 2022

May 13, 2022

SELL
$126.46 - $235.05 $2.73 Million - $5.07 Million
-21,559 Reduced 60.68%
13,971 $2.44 Million
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $3.86 Million - $6.3 Million
17,104 Added 92.83%
35,530 $8.94 Million
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $413,177 - $902,083
1,862 Added 11.24%
18,426 $6.98 Million
Q2 2021

Aug 16, 2021

SELL
$129.91 - $234.98 $5.01 Million - $9.06 Million
-38,565 Reduced 69.95%
16,564 $3.88 Million
Q1 2021

May 17, 2021

BUY
$109.18 - $185.98 $185,715 - $316,351
1,701 Added 3.18%
55,129 $6.53 Million
Q4 2020

Feb 16, 2021

SELL
$65.74 - $169.86 $982,550 - $2.54 Million
-14,946 Reduced 21.86%
53,428 $5.94 Million
Q3 2020

Nov 16, 2020

BUY
$54.34 - $94.85 $1.35 Million - $2.36 Million
24,884 Added 57.22%
68,374 $4.82 Million
Q2 2020

Aug 14, 2020

SELL
$29.67 - $80.0 $109,422 - $295,040
-3,688 Reduced 7.82%
43,490 $2.7 Million
Q1 2020

May 14, 2020

BUY
$17.78 - $31.58 $838,824 - $1.49 Million
47,178 New
47,178 $1.44 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $46.5B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track ETF Managers Group, LLC Portfolio

Follow ETF Managers Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.